Synaptic Pruning in Alzheimer’s Disease: Role of the Complement System

Synaptic Pruning in Alzheimer’s Disease: Role of the Complement System

Dr. Rick Brucato

Contact

Daniel E. Benjamin

Contact

Synaptic Pruning in Alzheimer’s Disease: Role of the Complement System

Article Fingerprint

ReserarchID

I5C75

Synaptic Pruning in Alzheimer’s Disease: Role of the Complement System Banner

AI TAKEAWAY

Connecting with the Eternal Ground

Abstract

Introduction-Alzheimer’s disease (AD) continues to threaten aged individuals and health care systems around the world. Human beings have been trying to postpone, reduce, or eliminate the primary risk factor for AD, aging, throughout history. Despite this, there is currently only symptomatic treatment for AD and this treatment is limited to only a handful of FDA approved AD drugs.

References

75 Cites in Article

Reference Format

Dean Sherzai,Ayesha Sherzai (2019). Preventing Alzheimer’s: Our Most Urgent Health Care Priority.
C Brookmeyer R Abdalla N Kawas,M Corrada (2017). forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
Biogen (1984). Filing Arguing Unpatentability of Biogen Application of Biogen Application.
Michael Rafii,Paul Aisen (2015). Advances in Alzheimer’s Disease Drug Development.
S Eleti (2016). Drugs in Alzheimer's disease Dementia: An overview of current pharmacological management and future directions.
Luke Bonham,Rahul Desikan,Jennifer Yokoyama (2016). The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease.
Luke Bonham,Ethan Geier,Chun Fan,Josiah Leong,Lilah Besser,Walter Kukull,John Kornak,Ole Andreassen,Gerard Schellenberg,Howard Rosen,William Dillon,Christopher Hess,Bruce Miller,Anders Dale,Rahul Desikan,Jennifer Yokoyama (2016). Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease.
David Fritzinger,Daniel Benjamin (2016). The Complement System in Neuropathic and Postoperative Pain.
B Morgan (2018). Complement in the pathogenesis of Alzheimer's disease.
D Tichaczek-Goska (2012). Deficiencies and excessive human complement system activation in disorders of multifarious etiology.
Lewis Watkins,James Neal,Sam Loveless,Iliana Michailidou,Valeria Ramaglia,Mark Rees,Richard Reynolds,Neil Robertson,B Morgan,Owain Howell (2016). Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Faith Brennan,John Lee,Marc Ruitenberg,Trent Woodruff (2016). Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Pablo Granados-Durán,María López-Ávalos,Timothy Hughes,Krista Johnson,B Morgan,Paul Tamburini,Pedro Fernández-Llebrez,Jesús Grondona (2016). Complement system activation contributes to the ependymal damage induced by microbial neuraminidase.
Heather M. Wilkins,Russell H. Swerdlow (2016). Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.
Fan Su,Feng Bai,Zhijun Zhang (2016). Inflammatory Cytokines and Alzheimer’s Disease: A Review from the Perspective of Genetic Polymorphisms.
Alexander Berg,Johan Zelano,Alexander Stephan,Sebastian Thams,Ben Barres,Milos Pekny,Marcela Pekna,Staffan Cullheim (2012). Reduced removal of synaptic terminals from axotomized spinal motoneurons in the absence of complement C3.
M Perez-Alcazar,J Daborg,A Stokowska,P Wasling,A Björefeldt,M Kalm,H Zetterberg,K Carlström,K Blomgren,C Ekdahl,E Hanse,M Pekna (2014). Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3.
Deng-Feng Zhang,Yu Fan,Min Xu,Guihong Wang,Dong Wang,Jin Li,Li-Li Kong,Hejiang Zhou,Rongcan Luo,Rui Bi,Yong Wu,Guo-Dong Li,Ming Li,Xiong-Jian Luo,Hong-Yan Jiang,Liwen Tan,Chunjiu Zhong,Yiru Fang,Chen Zhang,Nengyin Sheng,Tianzi Jiang,Yong-Gang Yao (2018). Complement C7is a novel risk gene for Alzheimer's disease in Han Chinese.
H Jiang,D Burdick,C Glabe,C Cotman,A Tenner (1994). beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain..
Andrés Crane,William Brubaker,Jenny Johansson,Abhishek Trigunaite,Justine Ceballos,Bonnie Bradt,Courtney Glavis‐bloom,Tanya Wallace,Andrea Tenner,Joseph Rogers (2017). Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy.
Qiaoqiao Shi,Kenneth Colodner,Sarah Matousek,Katherine Merry,Soyon Hong,Jessica Kenison,Jeffrey Frost,Kevin Le,Shaomin Li,Jean-Cosme Dodart,Barbara Caldarone,Beth Stevens,Cynthia Lemere (2015). ComplementC3-Deficient Mice Fail to Display Age-Related Hippocampal Decline.
Patrick Mcgeer,Joseph Rogers,Edith Mcgeer (2016). Inflammation, Antiinflammatory Agents, and Alzheimer’s Disease: The Last 22 Years.
Daniel Ricklin,George Hajishengallis,Kun Yang,John Lambris (2010). Complement: a key system for immune surveillance and homeostasis.
Michael Hernandez,Shan Jiang,Tracy Cole,Shu-Hui Chu,Maria Fonseca,Melody Fang,Lindsay Hohsfield,Maria Torres,Kim Green,Rick Wetsel,Ali Mortazavi,Andrea Tenner (2017). Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.
Junjie Hu,Yang Yang,Minli Wang,Yi Yao,Yanmin Chang,Quanwei He,Rong Ma,Gang Li (2019). Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways.
Tiffany Wu,Borislav Dejanovic,Vineela Gandham,Alvin Gogineni,Rose Edmonds,Stephen Schauer,Karpagam Srinivasan,Melanie Huntley,Yuanyuan Wang,Tzu-Ming Wang,Maj Hedehus,Kai Barck,Maya Stark,Hai Ngu,Oded Foreman,William Meilandt,Justin Elstrott,Michael Chang,David Hansen,Richard Carano,Morgan Sheng,Jesse Hanson (2019). Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy.
Borislav Dejanovic,Melanie Huntley,Ann De Mazière,William Meilandt,Tiffany Wu,Karpagam Srinivasan,Zhiyu Jiang,Vineela Gandham,Brad Friedman,Hai Ngu,Oded Foreman,Richard Carano,Ben Chih,Judith Klumperman,Corey Bakalarski,Jesse Hanson,Morgan Sheng (2018). Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
Alexandra Badea,Lauren Kane,Robert Anderson,Yi Qi,Mark Foster,Gary Cofer,Neil Medvitz,Anne Buckley,Andreas Badea,William Wetsel,Carol Colton (2016). The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.
Jon Toledo,Ané Korff,Leslie Shaw,John Trojanowski,Jing Zhang (2014). Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment.
Cornelia Pocnet,Jean-Philippe Antonietti,Alessia Donati,Julius Popp,Jérôme Rossier,Armin Von Gunten (2015). Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
F Duits,G Brinkmalm,C Teunissen,A Brinkmalm,P Scheltens,W Van Der Flier,H Zetterberg,K Blennow (2018). Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
Philip Insel,Oskar Hansson,R Mackin,Michael Weiner,Niklas Mattsson (2018). Amyloid pathology in the progression to mild cognitive impairment.
K Uchida,L Shan,H Suzuki,Y Tabuse,Y Nishimura,Y Hirokawa,K Mizukami,H Akatsu,K Meno,T Asada (2015). Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline Alzheimers Dement.
Jon Toledo,Xiao Da,Michael Weiner,David Wolk,Sharon Xie,Steven Arnold,Christos Davatzikos,Leslie Shaw,John Trojanowski (2014). CSF Apo-E levels associate with cognitive decline and MRI changes.
Sinika Ellendt,Bianca Voβ,Nils Kohn,Lisa Wagels,Katharina Goerlich,Eva Drexler,Frank Schneider,Ute Habel (2016). Predicting Stability of Mild Cognitive Impairment (MCI): Findings of a Community Based Sample.
I Korolev,L Symonds,A Bozoki (2016). Alzheimer's disease neuroimaging initiative. predicting progression from mild cognitive impairment to Alzheimer's dementia using clinical, mri, and plasma biomarkers via probabilistic pattern classification.
E Pavlopoulos,S Jones,S Kosmidis,M Close,C Kim,O Kovalerchik,S Small,E Kandel (2013). molecular mechanism for age-related memory loss: The histone-binding protein RbAp48.
Angharad Morgan,Samuel Touchard,Claire Leckey,Caroline O'hagan,Alejo Nevado‐holgado,Frederik Barkhof,Lars Bertram,Olivier Blin,Isabelle Bos,Valerija Dobricic,Sebastiaan Engelborghs,Giovanni Frisoni,Lutz Frölich,Silvey Gabel,Peter Johannsen,Petronella Kettunen,Iwona Kłoszewska,Cristina Legido‐quigley,Alberto Lleó,Pablo Martinez‐lage,Patrizia Mecocci,Karen Meersmans,José Molinuevo,Gwendoline Peyratout,Julius Popp,Jill Richardson,Isabel Sala,Philip Scheltens,Johannes Streffer,Hikka Soininen,Mikel Tainta‐cuezva,Charlotte Teunissen,Magda Tsolaki,Rik Vandenberghe,Pieter Visser,Stephanie Vos,Lars‐olof Wahlund,Anders Wallin,Sarah Westwood,Henrik Zetterberg,Simon Lovestone,B Morgan (2019). Inflammatory biomarkers in Alzheimer's disease plasma.
Hafdis Helgadottir,Pär Lundin,Emelie Wallén Arzt,Anna-Karin Lindström,Caroline Graff,Maria Eriksson (2019). Somatic mutation that affects transcription factor binding upstream of CD55 in the temporal cortex of a late-onset Alzheimer disease patient.
Zhi‐jie Han,Wei‐wei Xue,Lin Tao,Feng Zhu (2018). Identification of novel immune‐relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.
Insun Park,Ashwini Londhe,Ji Lim,Beoung-Geon Park,Seo Jung,Jae Lee,Sang Lim,Kyoung No,Jiyoun Lee,Ae Pae (2017). Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.
Elizabeth Spangenberg,Rafael Lee,Allison Najafi,Rachel Rice,Monica Elmore,Mathew Blurton-Jones,Brian West,Kim Green (2016). Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology.
Xiaolei Shi,Xiaoying Cai,Wei Di,Jie Li,Xiaotian Xu,Aiwu Zhang,Weiwei Qi,Zhiming Zhou,Yannan Fang (2016). MFG-E8 Selectively Inhibited Aβ-Induced Microglial M1 Polarization via NF-κB and PI3K-Akt Pathways.
Eva Czirr,Nicholas Castello,Kira Mosher,Joseph Castellano,Izumi Hinkson,Kurt Lucin,Bernat Baeza-Raja,Jae Ryu,Lulin Li,Sasha Farina,Nadia Belichenko,Frank Longo,Katerina Akassoglou,Markus Britschgi,John Cirrito,Tony Wyss-Coray (2017). Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity.
Jose Rubio-Perez,Juana Morillas-Ruiz (2012). A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines.
Oscar Bitzer-Quintero,Ignacio González-Burgos (2012). Immune System in the Brain: A Modulatory Role on Dendritic Spine Morphophysiology?.
B Stevens,N Allen,L Vazquez,G Howell,K Christopherson,N Nouri,K Micheva,A Mehalow,A Huberman,B Stafford,A Sher,A Litke,J Lambris,S Smith,S John,B Barres (2007). The classical complement cascade mediates cns synapse elimination.
Yuwen Wu,Lasse Dissing-Olesen,Brian Macvicar,Beth Stevens (2015). Microglia: Dynamic Mediators of Synapse Development and Plasticity.
M Fonseca,S Chu,M Hernandez,M Fang,L Modarresi,P Selvan,G Macgregor,A Tenner (2017). Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.
Xiao-Qun An,Wei Xi,Chen-Yun Gu,Xiao Huang (2018). Complement protein C5a enhances the β-amyloid-induced neuro-inflammatory response in microglia in Alzheimer’s disease.
Xueyuan Li,Xinjie Bao,Renzhi Wang (2016). Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review).
Syed Kazim,Khalid Iqbal (2016). Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease.
Ramón Cacabelos,Clara Torrellas,Oscar Teijido,Juan Carril (2016). Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease.
Elisa Uliassi,Annachiara Gandini,Rosaria Perone,Maria Bolognesi (2017). Neuroregeneration Versus Neurodegeneration: Toward a Paradigm Shift in Alzheimer'S Disease Drug Discovery.
Cheong-Meng Chong,Nana Ai,Simon Lee (2017). ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders.
Lawrence Fourgeaud,Lisa Boulanger (2007). Synapse Remodeling, Compliments of the Complement System.
Myles Minter,Juliet Taylor,Peter Crack (2007). The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Soyon Hong,Victoria Beja-Glasser,Bianca Nfonoyim,Arnaud Frouin,Shaomin Li,Saranya Ramakrishnan,Katherine Merry,Qiaoqiao Shi,Arnon Rosenthal,Ben Barres,Cynthia Lemere,Dennis Selkoe,Beth Stevens (2016). Complement and microglia mediate early synapse loss in Alzheimer mouse models.
Aswin Sekar,Allison Bialas,Heather De Rivera,Avery Davis,Timothy Hammond,Nolan Kamitaki,Katherine Tooley,Jessy Presumey,Matthew Baum,Vanessa Van Doren,Giulio Genovese,Samuel Rose,Robert Handsaker,Mark Daly,Michael Carroll,Beth Stevens,Steven Mccarroll (2016). Schizophrenia risk from complex variation of complement component 4.
Michele Zorzetto,Francesca Datturi,Laura Divizia,Cristiana Pistono,Ilaria Campo,Annalisa Silvestri,Mariaclara Cuccia,Giovanni Ricevuti (2017). Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.
Alexander Stephan,Daniel Madison,José Mateos,Deborah Fraser,Emilie Lovelett,Laurence Coutellier,Leo Kim,Hui-Hsin Tsai,Eric Huang,David Rowitch,Dominic Berns,Andrea Tenner,Mehrdad Shamloo,Ben Barres (2013). A Dramatic Increase of C1q Protein in the CNS during Normal Aging.
Kalen Berry,Elly Nedivi (2017). Spine Dynamics: Are They All the Same?.
Hiroyuki Okuno,Keiichiro Minatohara,Haruhiko Bito (2017). Inverse synaptic tagging: An inactive synapse-specific mechanism to capture activity-induced Arc/arg3.1 and to locally regulate spatial distribution of synaptic weights.
Mahima Sharma,Tobias Dierkes,Sreedharan Sajikumar (2017). Epigenetic regulation by G9a/<scp>GLP</scp> complex ameliorates amyloid‐beta 1‐42 induced deficits in long‐term plasticity and synaptic tagging/capture in hippocampal pyramidal neurons.
A Park,R Havekes,X Fu,R Hansen,J Tudor,L Peixoto,Z Li,Y Wu,S Poplawski,J Baraban,T Abel (2017). Learning induces the translin/trax RNase complex to express active in receptors for persistent memory.
Brian Zingg,Xiao-Lin Chou,Zheng-Gang Zhang,Lukas Mesik,Feixue Liang,Huizhong Tao,Li Zhang (2016). AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors.
Paolina Crocco,Adolfo Saiardi,Miranda Wilson,Raffaele Maletta,Amalia Bruni,Giuseppe Passarino,Giuseppina Rose (2016). Contribution of polymorphic variation of inositol hexakisphosphate kinase 3 ( IP6K3 ) gene promoter to the susceptibility to late onset Alzheimer's disease.
Jessy Presumey,Allison Bialas,Michael Carroll (2017). Complement System in Neural Synapse Elimination in Development and Disease.
A Miyamoto,H Wake,A Moorhouse,J Nabekura (2013). Microglia and synapse interactions: fine tunin g neural circuits and candidate molecules.
A Pliássova,P Canas,A Xavier,B Da Silva,R Cunha,P Agostinho (2016). Age-related changes in the synaptic density of amyloidβ protein precursor and secretases in the human cerebral cortex.
Vincent On,Atena Zahedi,Iryna Ethell,Bir Bhanu (2017). Automated spatio-temporal analysis of dendritic spines and related protein dynamics.
E Danielson,S Lee (2014). SynPAnal: Software for rapid quantification of the density and intensity of protein puncta from fluorescence microscopy images of neurons.
Jinhua Wang,Jie Yuan,Jingjuan Pang,Jiang Ma,Bing Han,Yuan Geng,Li Shen,Hualong Wang,Qinying Ma,Yanyong Wang,Mingwei Wang (2016). Effects of Chronic Stress on Cognition in Male SAMP8 Mice.
Wensen Pan,Shuo Han,Lin Kang,Sha Li,Juan Du,Huixian Cui (2016). Effects of dihydrotestosterone on synaptic plasticity of the hippocampus in mild cognitive impairment male SAMP8 mice.
Yan-Li Jia,Su-Juan Sun,Jing-Hong Chen,Qian Jia,Tian-Tian Huo,Li-Fang Chu,Jiang-Tao Bai,Ye-Jing Yu,Xiao-Xin Yan,Jian-Hua Wang (2016). SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. Rick Brucato. 2020. \u201cSynaptic Pruning in Alzheimer’s Disease: Role of the Complement System\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 20 (GJMR Volume 20 Issue F6): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 20 Issue F6
Pg. 1- 20

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-F Classification: NLMC Code: WT 155

Submission ReceivedDecember 11, 2019
Peer Review Double Blind
Handling Editor
Accepted January 4, 2020
Published January 15, 2020

Version of record

v1.2

Issue date

June 29, 2020

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 2315

Total Downloads: 1133

2026 Trends

Published Article

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]